Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer

MLA

Yosuke Makuuchi, et al. Pre‐emptive Antifungal Therapy versus Empirical Antifungal Therapy for Febrile Neutropenia in People with Cancer. May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6297a6c3ebc7f174fc4e5487f4eef1aa&authtype=sso&custid=ns315887.

APA

Yosuke Makuuchi, Norio Watanabe, Kentaro Tochitani, Yu Uneno, & Haruki Imura. (2020). Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.

Chicago

Yosuke Makuuchi, Norio Watanabe, Kentaro Tochitani, Yu Uneno, and Haruki Imura. 2020. “Pre‐emptive Antifungal Therapy versus Empirical Antifungal Therapy for Febrile Neutropenia in People with Cancer,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6297a6c3ebc7f174fc4e5487f4eef1aa&authtype=sso&custid=ns315887.